These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2219021)

  • 1. [Intravenous drug users and contact with the health care system].
    Skretting A
    Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2553-6. PubMed ID: 2219021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous drug users and the HIV epidemic].
    Skretting A
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1981-4. PubMed ID: 1509465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of drug abuse treatment programs in AIDS prevention and education programs for intravenous drug users: the New Jersey experience.
    Jackson JF; Rotkiewicz LG; Baxter RC
    NIDA Res Monogr; 1990; 93():167-86. PubMed ID: 2300140
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV infection among drug abusers in the Belgrade area.
    Kilibarda M
    Bull Narc; 1993; 45(1):135-46. PubMed ID: 8305903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
    Appel PW; Oldak R
    Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
    Day C; Ross J; Dolan K
    Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of 'visible' and 'invisible' users of amphetamine, cocaine and heroin: two distinct populations?
    Robson P; Bruce M
    Addiction; 1997 Dec; 92(12):1729-36. PubMed ID: 9581005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug users attending general practice in Eastern Regional Health Authority (ERHA) area.
    Cullen W; Bury G; Barry J; O'Kelly F
    Ir Med J; 2000 Oct; 93(7):214-7. PubMed ID: 11142958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
    Warner LA; Alegría M; Canino G
    Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of health care utilization among HIV-seropositive injection drug users.
    Mizuno Y; Wilkinson JD; Santibanez S; Dawson Rose C; Knowlton A; Handley K; Gourevitch MN;
    AIDS Care; 2006 Jul; 18(5):417-25. PubMed ID: 16777632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of amphetamine use in New Zealand: findings from the 2001 National Drug Survey.
    Wilkins C; Pledger M; Bhatta K; Casswell S
    N Z Med J; 2004 Mar; 117(1190):U796. PubMed ID: 15107899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?
    Kelley MS; Chitwood DD
    Soc Sci Med; 2004 May; 58(10):2083-92. PubMed ID: 15020021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
    de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
    Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for hepatitis C among injecting drug users in Oslo].
    Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.